Nanochon’s Chondrograft™ device is a sturdy medical advancement that is one-part orthopedic load-bearing implant, one part tissue growth scaffold, and completely revolutionary. Our implant replaces lost or damaged cartilage and encourages new growth using innovative nanomaterial and 3-D printed designs. This technology has the potential to provide a more successful, faster, longer-lasting, and more affordable solution to joint disease and injury. Nanochon was founded in 2016 by Dr.s Ben Holmes and Nathan Castro. Both passionate inventors, they have brought in experienced medical device developers, executives and some of the top names in sports medicine to commercialize Chondrograft™. Backed by VCs, notable angels and a strategic investor, Nanochon is poised to enter the clinic in 2023, and be market ready by 2026.